Provider review
Sipra review
By The Dose Brief Desk · Updated
Sipra’s lowest GLP-1 rates require a twelve-month plan, and stopping the next pharmacy order requires thirteen days of notice.
Not rated. This review examines published program information; it is not a firsthand treatment review.
At a glance
- Semaglutide
- Injection from $149/month on a twelve-month plan
- Tirzepatide
- Injection from $199/month advertised; confirm selected term
- Availability
- Advertises all 50 states; actual medication availability varies by state.
- Treatment formats
- Compounded semaglutide/B12 and tirzepatide/B12 injections; separately priced dissolvable-tablet options.
Plan total is charged after clinical approval. Cancel at least 13 days before the paid period ends; longer-plan exit terms apply.
The lowest rate has a long-plan condition
Sipra advertises injectable semaglutide from $149 a month and tirzepatide from $199. A footnote identifies the $149 starting rate as the twelve-month-plan price. The total plan charge, rather than the monthly equivalent alone, is the number to compare before paying.
Payment and dose changes
The FAQ says the plan total is charged once after physician approval and includes follow-up, support and expedited shipping. It describes pricing based on plan length rather than prescribed dose, with notice before a changed renewal rate. Ask for the selected term’s total and how medication is shipped over that term.
Thirteen days is the practical cancellation deadline
Sipra says cancellation is available online, but stopping the next order requires at least thirteen days of notice before the paid period ends. An order sent to the pharmacy cannot be stopped. Leaving a six- or twelve-month plan early is subject to its terms, so cancel-anytime language is not an unconditional refund promise.
Keep oral offers separate
The catalog also markets SemaMelt and TirzaMelt dissolvable products and smaller-dose programs. These have separate prices and formulations. Ask why the clinician recommends the particular preparation, which pharmacy supplies it and what support is available; do not infer equivalence from a shared ingredient name.
What stands out
- Discloses approval-before-charge and dose-price approach
- Gives a specific online-cancellation cutoff
What to check
- Lowest semaglutide headline requires twelve months
- Long-plan early exit and pharmacy processing limit flexibility
Sources and review scope
Public information checked in October 2026. Prices and eligibility can change. We have not enrolled in treatment, independently tested medications or verified the licenses of the clinicians and pharmacies involved in an individual prescription. Compounded medications are not FDA-approved; studies of approved brands do not establish that a compounded product has the same safety or effectiveness.